Who’s on your bench?
As healthcare professionals, expertise matters; but so does the support system behind it.
Your career isn’t shaped only by what you know, but by who helps you think, decide, recover, and grow through each stage of it.
In the final episode of the LEADderm mini-series, we explore the “bench” every high performer needs and why no one succeeds alone.
We’re joined by clinician Dr Jennifer Soung and business leader Nita Nautiyal to unpack how the right people around you can influence resilience, decision-making, and long-term wellbeing.
We discuss:
• The five roles that strengthen your personal and professional support system
• Why connection is an essential career skill, not a soft extra
• How intentional relationships shape how you respond to challenge
• Why events like LEADderm can be a great starting point for building your network
Take a moment to ask yourself: who’s on your bench and who’s missing?
Listen now: https://t.co/Tjz5IzqRfi
#LEADderm #Dermatology #MedicalLeadership #HealthcareProfessionals #HCPEducation
📢 Don’t forget to nominate your touchINFECTIOUS DISEASES Future Leader 2026.
Last year, we recognised Dr Simon Feys as a Future Leader 2025:
“Being recognised as a Future Leader was a true honour. Medicine humbles me everyday. To be called a Future Leader only deepened that commitment, and reinforced my path as clinician-scientist.”
Is there a rising star in infectious diseases who should be recognised in 2026?
✨ Make your nomination today:
https://t.co/yh8zea4Mav
Revisit our 2025 Future Leaders here:
https://t.co/nAuTKCz6Ck
#InfectiousDiseases #MedicalEducation #FutureLeaders #GlobalHealth #MedicalResearch #HealthcareProfessionals
Nominations for touchINFECTIOUS DISEASES Future Leaders 2026 are now open.
Do you know a rising star in infectious diseases who is driving innovation, improving patient outcomes or advancing research?
We would love to hear from you.
✨ Make your nomination today:
https://t.co/yh8zea4Mav
📄 Full nomination criteria is available through the link above.
#InfectiousDiseases #MedicalEducation #FutureLeaders #GlobalHealth #MedicalResearch #HealthcareProfessionals
🚨 We’re now on TikTok 🚨
Touch Medical Media has officially launched on TikTok.
Follow us for fresh, engaging content created for healthcare professionals from clinically relevant insights and key medical updates to behind-the-scenes moments.
Expect:
👀 Bite-sized expert insights
🎥 Behind-the-scenes content
🩺 Thought-provoking healthcare stories
⚡ Fast, relevant updates
Be among the first to follow us and join the journey.
📲 Follow us here: https://t.co/FBbArg7hyf
#TouchMedicalMedia #TikTok #HealthcareContent #MedicalEducation #HCP #DigitalHealth #MedComms
🦠 IMARI 2026: Interdisciplinary action to confront antimicrobial resistance
The inaugural Interdisciplinary Meeting on Antimicrobial Resistance and Innovation 2026 brought together researchers, clinicians, industry leaders and policymakers to address one of the most urgent threats in modern medicine: antimicrobial resistance (AMR).
Read the full highlights: https://t.co/ieUgxkNXGS
#AntimicrobialResistance #InfectiousDiseases #Microbiology
✨ We are delighted to announce that nominations are now open for touchINFECTIOUS DISEASES Future Leaders 2026.
This initiative recognises emerging leaders in infectious diseases who are already making meaningful contributions to research, clinical practice, education and collaboration, and who are helping shape the future of the field.
✨ Submit your nomination today:
https://t.co/yh8zea4Mav
📄 Full nomination criteria is available through the link above.
#InfectiousDiseases #MedicalEducation #FutureLeaders #GlobalHealth #MedicalResearch #HealthcareProfessionals
📢 Rebuilding vaccine confidence after COVID-19: Practical guidance for clinicians
Vaccine confidence has shifted significantly in the wake of the COVID-19 pandemic, with important implications for routine immunisation, vaccine catch-up and equitable access to care.
In this Q&A, Prof. Nada M. Melhem (American University of Beirut) explores how confidence has evolved post-pandemic, how clinicians can interpret current guidance on vaccine hesitancy, and the practical steps HCPs can take to address missed vaccinations and structural barriers to uptake.
🔗 Read more: https://t.co/UIIkJTPAQp
#Vaccines #Immunisation #InfectiousDiseases
🌍 Strengthening global infectious disease control
From outbreak surveillance and pandemic preparedness to education and global collaboration, the International Society for Infectious Diseases @ISID_org continues to play a key role in advancing infectious disease control worldwide.
In this latest interview, ISID discusses:
🦠 The need for co-ordinated global infectious disease response
📡 How ProMED supports early outbreak detection and surveillance
📚 Expanding access to infectious disease education and training
🌐 Strengthening collaboration across the global One Health community
Explore the full interview and discover how ISID is helping shape the future of infectious disease prevention and preparedness:
https://t.co/NqRYAdZOaH
#InfectiousDiseases #GlobalHealth #OneHealth #PublicHealth #PandemicPreparedness
📢 Bridging the Diagnostic Gap in Bacterial Vaginosis
Bacterial vaginosis (BV) remains one of the most common vaginal infections worldwide, yet diagnosis is often challenging. Conventional methods like Amsel’s criteria and Nugent scoring are limited by subjectivity, cost, and accessibility, while misdiagnosis affects up to 50% of cases.
In this interview, Dr Olivia (Libby) Van Gerwen (University of Alabama at Birmingham) explores how point-of-care diagnostics and emerging molecular tests could transform BV diagnosis, improve accuracy, and deliver more patient-centred care.
📍 Read: https://t.co/EMIoFmwmML
#BacterialVaginosis #BV #Diagnostics
🌍 Today is World AIDS Vaccine Day | 18 May
World AIDS Vaccine Day highlights the urgent need for a safe and effective vaccine to prevent HIV and ultimately end the epidemic. While antiretroviral therapy and prevention strategies have transformed HIV care, a vaccine remains essential to achieving long-term global control.
This day also recognises the dedication of scientists, healthcare professionals and communities working to advance vaccine research and innovation. Continued collaboration and investment will be critical to accelerating progress toward an HIV-free future.
Explore the latest expert insights, research updates and educational content in HIV:
https://t.co/A0bophgrrr
We’re proud to mark this important day alongside our media partner, the International Society for Infectious Diseases @ISID_org, supporting global efforts to advance prevention and improve outcomes in infectious diseases.
@EACSociety@iasociety
#WorldAIDSVaccineDay #HIV #Vaccines #InfectiousDiseases #GlobalHealth #Prevention #touchINFECTIOUSDISEASES
📣 We’re excited to announce the launch of our new TikTok channel - Touch Medical Media!
We’re expanding our digital presence to bring you engaging, informative, and high-quality medical content in a fresh and accessible format.
🎥 From insightful health updates to behind-the-scenes perspectives in medical media, there’s plenty more on the way, so watch this space!
👉 Follow us now on TikTok and be part of the journey as new content rolls out soon - https://t.co/FBbArg7hyf
Stay tuned, exciting things are coming.
#TouchMedicalMedia #TikTokLaunch #MedicalEducation #FollowUs
🌍 #ESCMIDGlobal2025: Tackling Antibiotic Resistance
Dr Dariusz Hareza (Northwestern University) highlights key insights from ESCMID Global 2025:
💡 Takeaways:
🔹Global action: Kazakhstan’s primary care AMR initiatives show local solutions matter.
🔹One Health: Resistance spreads across humans, animals, and environment.
🔹Innovation: CRISPR and AI offer future tools for targeting resistance and outbreak response.
🔗 Full coverage: https://t.co/gJPh1b3MYR
#AntimicrobialResistance #InfectiousDiseases
📢 ESCMID 2026: Rethinking respiratory virus transmission 🦠
At ESCMID 2026, Dr Daniel Pan discusses emerging approaches to understanding respiratory virus transmission and measuring individual infectiousness.
Recognized as a touchINFECTIOUS DISEASES Future Leader 2026 and recipient of a Young Investigator Award, Dr Pan reflects on lessons from the COVID-19 pandemic, the role of transmission science in future infectious diseases research and the impact of health inequalities on infection risk.
Read more: https://t.co/hUkQdu6tFf
#ESCMID2026 #InfectiousDiseases #PublicHealth #RespiratoryViruses #TransmissionScience
📢 Hantavirus in 2026: What clinicians need to know about the emerging global concern
Recent updates from international public health agencies have renewed attention on hantavirus infections, with increased reporting activity prompting refreshed clinical guidance and awareness.
Although human infection remains uncommon in many regions, hantavirus continues to be an important zoonotic pathogen with potential for severe disease in selected cases, particularly in endemic areas.
This update outlines key considerations for clinicians around recognition, exposure risk and evolving public health surveillance priorities.
Read more: https://t.co/SJ7aG5M0T2
#Hantavirus #InfectiousDisease #PublicHealth #Zoonoses #ClinicalAwareness #GlobalHealth
📢 ESCMID 2026: AI in infectious disease care 🤖
As innovation accelerates, how do we ensure AI-enabled tools are trusted, adopted and effective in real-world settings?
At ESCMID Global 2026, Prof. Holly Seale highlights the importance of moving beyond technology alone - emphasising the critical role of public trust, communication and meaningful engagement in successful implementation.
In this interview, she explores the challenges of deploying AI diagnostics in remote and underserved communities, from infrastructure and workforce limitations to digital literacy, ethics and equity considerations.
Read more: https://t.co/51zG0niSip
#ESCMID2026 #ArtificialIntelligence #InfectiousDiseases #PublicHealth #HealthEquity
📢 Advancing fungal disease diagnosis through host immunity 🧬
At ESCMID Global 2026, Dr Sarah Delliere reflects on how a deeper understanding of host immunity could reshape the diagnosis and treatment of invasive fungal infections.
In this interview, she highlights a shift away from focusing solely on the pathogen towards the role of the host immune response - opening the door to more precise diagnostics, improved differentiation between infection and colonisation, and new therapeutic strategies aimed at restoring immune balance.
She also discusses the importance of collaboration in a field where rare but highly lethal infections demand cross-border research, as well as the value of mentorship and visibility in strengthening the future of medical mycology.
Read more: https://t.co/bfuRSkhOFF
#ESCMID2026 #MedicalMycology #InfectiousDiseases #FungalInfections #HostImmunity #Diagnostics
Proud to be trusted by leaders in MedEd
Trusted by experts. Valued by partners. Focused on impact.
We believe the best measure of our work comes from the professionals we collaborate with every day. From meaningful partnerships to high-quality educational initiatives, we’re proud to support those driving progress in healthcare.
Hear what Dr Christoph Boesecke has to say about working with us and the value of partnering together.
Real voices. Real value. Real impact.
Join the community today. Register now: https://t.co/u16VusoCUu
#MedicalEducation #HealthcareLeadership #Partnership #HealthcareCommunity #TrustedVoices
📢 ESCMID 2026: Could phage therapy transform treatment of resistant infections? 🦠
As antimicrobial resistance continues to rise, alternative approaches to bacterial infection management are gaining attention.
At ESCMID 2026, Dr Ikechukwu Benjamin Moses presented early research exploring bacteriophage-based strategies targeting resistant Staphylococcus pseudintermedius, an emerging zoonotic pathogen associated with companion animals.
In this interview, he discusses how his work evolved from One Health surveillance into phage therapy research, alongside the potential of bacteriophage-derived treatments and emerging delivery innovations such as microneedle systems.
Read more: https://t.co/JJlkVDT938
#ESCMID2026 #AMR #AntimicrobialResistance #PhageTherapy #InfectiousDiseases #OneHealth
📢 ESCMID 2026: Rethinking Respiratory Infection Prevention 🦠
How should vaccine strategies evolve to better reflect patient priorities?
At ESCMID Global 2026, Prof. Holly Seale highlights the need to move beyond traditional messaging focused on hospitalisation and mortality, recognising the broader long-term impacts of respiratory infections.
🔍 Key themes include:
• The impact of infections on frailty, cognition and independence
• Aligning prevention strategies with what matters most to patients
• The role of combination and concurrent vaccination approaches
• Improving equitable access to vaccination
As prevention strategies continue to evolve, a more patient-centred approach will be key to reducing the burden of respiratory infections.
Read more: https://t.co/7BTCEIERus
#ESCMID2026 #Vaccines #RespiratoryInfections #PublicHealth #Prevention #Healthcare
🚨 We’re now on TikTok 🚨
Touch Medical Media has officially launched on TikTok.
Follow us for fresh, engaging content created for healthcare professionals from clinically relevant insights and key medical updates to behind-the-scenes moments.
Expect:
👀 Bite-sized expert insights
🎥 Behind-the-scenes content
🩺 Thought-provoking healthcare stories
⚡ Fast, relevant updates
Be among the first to follow us and join the journey.
📲 Follow us here: https://t.co/FBbArg7hyf
#TouchMedicalMedia #TikTok #HealthcareContent #MedicalEducation #HCP #DigitalHealth #MedComms